Association between glucose variability and adverse in-hospital outcomes for Chinese patients with acute coronary syndrome

Saudi Medical Journal

Volumn 31, Issue 10, 2010, Pages 1146-1151

  Zhang, Xue Lian ^a   Lu, Ju Ming ^b   Shan, Guang Liang ^c   Yang, Zhao Jun ^a   Yang, Wen Ying ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALIDITY;

ACUTE CORONARY SYNDROME; AGED; BLOOD GLUCOSE; CHINA; COHORT STUDIES; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 78651105545     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Meier JJ, Deifuss S, Klamann A, Launhardt V, Schmiegel WH, Nauck MA. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diab Care 2005; 28: 2551-2553.
2. Vivas D, Garcia-Rubira JC, Gonzalez-Ferrer JJ, Nunez-Gil I, del Prado N, Fernandez-Ortiz A, et al. [Prognostic value of irst fasting glucose measurement compared with admission glucose level in patients with acute coronary syndrome] Rev Esp Cardiol 2008; 61: 458-464.Spanish.
3. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111: 754-760.
4. Cao JJ, Hudson M, Jankowski M, Whitehouse F, Weaver WD. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol 2005; 96: 183-186.
5. Otten R, Kline-Rogers E, Meier DJ, Dumasia R, Fang J, May N, et al. Impact of pre-diabetic state on clinical outcomes in patients with acute coronary syndrome. Heart 2005; 91: 1466-1468.
6. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, et al. Glucometrics in patients hospitalized with acute myocardial infarction: deining the optimal outcomes-based measure of risk. Circulation 2008; 117: 1018-1027.
7. Goyal A, Mahafey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, et al. Prognostic signiicance of the change in glucose level in the irst 24 hours after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006; 27: 1289-1297.
8. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): efects on mortality and morbidity. Eur Heart J 2005; 26: 650-661.
9. Cheung NW, Wong VW, McLean M. he Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006; 29: 765-770.
10. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
11. Coester A, Neumann CR, Schmidt MI. Intensive insulin therapy in severe traumatic brain injury: a randomized trial. J Trauma 2010; 68: 904-911.
12. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: beneit versus harm. Diabetes 2006; 55: 3151-3159.
13. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G. Dynamic characteristics of blood glucose time series during the course of critical illness: efects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010; 38: 1021-1029.
14. Ali NA, O'Brien JM Jr, Dungan K, Phillips G, Marsh CB, Lemeshow S, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008; 36: 2316-2321.
15. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105: 244-252.
16. Krinsley JS. Glycemic variability in critically ill patients: impact of diabetes. J Diab Sci Tech 2009; 3: 1292-1301.
17. GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001; 141: 190-199.
18. Yan AT, Yan RT, Tan M, Eagle KA, Granger CB, Dabbous OH, et al. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratiied by the GRACE risk score. Am J Cardiol 2005; 96: 913-916.
19. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345-2353.
20. Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna RC, Moghetti P, et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 2000; 23: 45-50.
21. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, et,al. Glucometrics in patients hospitalized with acute myocardial infarction: deining the optimal outcomes-based measure of risk. Circulation 2008; 117: 1018-1027.
22. Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010; 38: 838-842.
23. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297.
24. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001; 15: 533-551.
25. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52: 2795-2804.
26. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007; 117: 910-918.
27. Ceriello A, Esposito K, Piconi L, Ihnat MA, horpe JE, Testa R, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57: 1349-1354.
28. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005; 19: 178-181.
29. van der Horst IC, Gans RO, Nijsten MW, Ligtenberg JJ. Beneicial efect of glucose-insulin-potassium infusion in noncritically ill patients has to be proven. J Intern Med 2003; 254: 513-514.